title: Ingrown toenail and indinavir: case-control study demonstrates strong relationship.
authors.forename: Y
authors.initials: Y
authors.lastname: Bourezane
authors.forename: B
authors.initials: B
authors.lastname: Thalamy
authors.forename: J F
authors.initials: JF
authors.lastname: Viel
authors.forename: K
authors.initials: K
authors.lastname: Bardonnet
authors.forename: C
authors.initials: C
authors.lastname: Drobacheff
authors.forename: H
authors.initials: H
authors.lastname: Gil
authors.forename: D A
authors.initials: DA
authors.lastname: Vuitton
authors.forename: B
authors.initials: B
authors.lastname: Hoen
mesh_terms: D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009263:Nails, Ingrown / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir